AAD 2026Abstract 72213Clinical trial
Sustained Health-Related Quality of Life and work productivity improvements with Delgocitinib 20 mg/g Cream in Chronic Hand Eczema - Results from the Phase 3 Open-Label Extension DELTA 3 Trial
Armstrong A, Gold LS, Bauer A, Greig J, Norlin JM, Thoning H, Agner T
AAD Annual Meeting 2026Denver, 27–31 Mar 2026 · published in JAAD 6 Jul 2026
Topics: Atopic dermatitis & eczemaContact dermatitis
Abstract
The abstract’s text is on the JAAD website.
DOI 10.1016/j.jaad.2026.04.1681 · Not in PubMed: details from Crossref